These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30137296)

  • 1. Single vs. dual chamber implantable cardioverter-defibrillators or programming of implantable cardioverter-defibrillators in patients without a bradycardia pacing indication: systematic review and meta-analysis.
    Zeitler EP; Sanders GD; Singh K; Greenfield RA; Gillis AM; Wilkoff BL; Piccini JP; Al-Khatib SM
    Europace; 2018 Oct; 20(10):1621-1629. PubMed ID: 30137296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiencies and Complications of Dual Chamber versus Single Chamber Implantable Cardioverter Defibrillators in Secondary Sudden Cardiac Death Prevention: A Meta-analysis.
    Hu ZY; Zhang J; Xu ZT; Gao XF; Zhang H; Pan C; Chen SL
    Heart Lung Circ; 2016 Feb; 25(2):148-54. PubMed ID: 26338316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual- vs. single-chamber defibrillators for primary prevention of sudden cardiac death: long-term follow-up of the Défibrillateur Automatique Implantable-Prévention Primaire registry.
    Defaye P; Boveda S; Klug D; Beganton F; Piot O; Narayanan K; Périer MC; Gras D; Fauchier L; Bordachar P; Algalarrondo V; Babuty D; Deharo JC; Leclercq C; Marijon E; Sadoul N;
    Europace; 2017 Sep; 19(9):1478-1484. PubMed ID: 28340096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.
    Tan VH; Wilton SB; Kuriachan V; Sumner GL; Exner DV
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):164-70. PubMed ID: 24446023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention.
    Friedman PA; Bradley D; Koestler C; Slusser J; Hodge D; Bailey K; Kusumoto F; Munger TM; Militanu A; Glikson M
    Europace; 2014 Oct; 16(10):1460-8. PubMed ID: 24928948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results.
    Auricchio A; Schloss EJ; Kurita T; Meijer A; Gerritse B; Zweibel S; AlSmadi FM; Leng CT; Sterns LD;
    Heart Rhythm; 2015 May; 12(5):926-36. PubMed ID: 25637563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are dual-chamber implantable cardioverter-defibrillators really better than single-chamber ones? A systematic review and meta-analysis.
    Chen BW; Liu Q; Wang X; Dang AM
    J Interv Card Electrophysiol; 2014 Apr; 39(3):273-80. PubMed ID: 24532113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention.
    Peterson PN; Varosy PD; Heidenreich PA; Wang Y; Dewland TA; Curtis JP; Go AS; Greenlee RT; Magid DJ; Normand SL; Masoudi FA
    JAMA; 2013 May; 309(19):2025-34. PubMed ID: 23677314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
    Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
    Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single- Versus Dual-Chamber Implantable Cardioverter-Defibrillator for Primary Prevention of Sudden Cardiac Death in the United States.
    Margolis G; Hamuda N; Kobo O; Elbaz Greener G; Amir O; Homoud M; Madias C; Heist EK; Ruskin JN; Kazatsker M; Roguin A; Leshem E; Rozen G
    J Am Heart Assoc; 2023 Aug; 12(15):e029126. PubMed ID: 37522389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Detection Programming in Single-Chamber Defibrillators Reduces Unnecessary Therapies and Mortality: The ADVANCE III Trial.
    Gasparini M; Lunati MG; Proclemer A; Arenal A; Kloppe A; Martínez Ferrer JB; Hersi AS; Gulaj M; Wijffels MCE; Santi E; Manotta L; Varma N
    JACC Clin Electrophysiol; 2017 Nov; 3(11):1275-1282. PubMed ID: 29759624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial.
    Almendral J; Arribas F; Wolpert C; Ricci R; Adragao P; Cobo E; Navarro X; Quesada A; ; ;
    Europace; 2008 May; 10(5):528-35. PubMed ID: 18390985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The subcutaneous implantable cardioverter-defibrillator in review.
    Kamp NJ; Al-Khatib SM
    Am Heart J; 2019 Nov; 217():131-139. PubMed ID: 31654943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
    Basu-Ray I; Liu J; Jia X; Gold M; Ellenbogen K; DiNicolantonio J; Komócsi A; Vorobcsuk A; Kim J; Afshar H; Lam W; Mathuria N; Razavi M; Rasekh A; Saeed M
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1475-1483. PubMed ID: 29759827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Use of Single- vs Dual-Chamber Implantable Cardioverter-Defibrillators Among Patients Without a Pacing Indication, 2010-2018.
    Borne RT; Varosy P; Lan Z; Masoudi FA; Curtis JP; Matlock DD; Peterson PN
    JAMA Netw Open; 2022 Mar; 5(3):e223429. PubMed ID: 35315917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transvenous versus subcutaneous implantable cardioverter defibrillators in young cardiac arrest survivors.
    Morton MB; Mariani JA; Kistler PM; Patel H; Voskoboinik A
    Intern Med J; 2023 Nov; 53(11):1956-1962. PubMed ID: 37929818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable defibrillators versus medical therapy for cardiac channelopathies.
    McNamara DA; Goldberger JJ; Berendsen MA; Huffman MD
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD011168. PubMed ID: 26445202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.